Search results for "INCIDENCE"

showing 10 items of 2270 documents

Risk of second primary cancers in women diagnosed with endometrial cancer in G erman and S wedish cancer registries

2017

Along with the increasing incidence and favorable prognosis, more women diagnosed with endometrial cancer may develop second primary cancers (SPCs). We aimed at investigating risk of SPCs after endometrial cancer in Germany and Sweden to provide insight into prevention strategies for SPCs. Endometrial cancer patients diagnosed at age ≥15 years in Germany during 1997-2011 and in Sweden nationwide during 1997-2012 were selected. Standardized incidence ratios (SIRs), calculated as the ratio of observed to expected numbers of cases, were used to assess the risk of a specific second cancer after endometrial cancer for both German and Swedish datasets. Among 46,929 endometrial cancer survivors in…

Adult0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyAdolescentYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsGermanyInternal medicineEpidemiology of cancermedicineHumansRegistriesYoung adultAgedAged 80 and overSwedenGynecologyCancer preventionbusiness.industryIncidenceEndometrial cancerIncidence (epidemiology)CancerNeoplasms Second PrimaryMiddle Agedmedicine.diseaseEndometrial NeoplasmsCancer registry030104 developmental biologyOncology030220 oncology & carcinogenesisFemalebusinessKidney cancerInternational Journal of Cancer
researchProduct

Outcomes of single versus double hormone receptor–positive breast cancer. A GEICAM/9906 sub-study

2018

Abstract Background Retrospective data suggest better outcomes for patients with double hormonal receptor (oestrogen [ER] and progesterone receptor [PgR])–positive (dHR+) early breast cancer, compared with single hormonal receptor–positive, sHR+, (ER+/PgR– or ER–/PgR+) disease. Here, we evaluate the classification according to intrinsic subtypes and clinical outcomes of sHR+ versus dHR+ in HER2-negative breast cancer patients enrolled in GEICAM/9906 study ( NCT00129922 ). Methods Archival tumours were retrieved retrospectively for the analysis of ER, PgR and HER2 status and classified into intrinsic subtypes using the PAM50 gene expression assay. Disease-free survival (DFS) and overall surv…

Adult0301 basic medicineOncologyendocrine systemCancer Researchmedicine.medical_specialtyPaclitaxelBreast NeoplasmsDisease-Free Survival03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsProgesterone receptormedicineHumansPAM50Single receptor positiveskin and connective tissue diseasesReceptorCyclophosphamideAgedEpirubicinProportional Hazards ModelsRandomized Controlled Trials as TopicRetrospective StudiesHormone receptor positivebusiness.industryIncidence (epidemiology)Hazard ratioLuminal aMiddle Agedmedicine.disease030104 developmental biologyClinical Trials Phase III as TopicReceptors EstrogenOncologyIntrinsic subtypesHormone receptor030220 oncology & carcinogenesisFemaleFluorouracilReceptors ProgesteroneTranscriptomebusinesshormones hormone substitutes and hormone antagonistsHormoneEuropean Journal of Cancer
researchProduct

The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory suppor…

2016

Shahid Husain, MD, MS, Amparo Sole, MD, PhD, Barbara D. Alexander, MD, MHS, Saima Aslam, MD, MS, Robin Avery, MD, Christian Benden, MD, Eliane M. Billaud, PharmD, PhD, Daniel Chambers, MBBS, MD, Lara Danziger-Isakov, MD, Savitri Fedson, MD, Kate Gould, MD, Aric Gregson, MD, Paolo Grossi, MD, PhD, Denis Hadjiliadis, MD, Peter Hopkins, MD, Me-Linh Luong, MD, Debbie J.E. Marriott, MD, Victor Monforte, MD, Patricia Munoz, MD, PhD, Alessandro C. Pasqualotto, MD, PhD, Antonio Roman, MD, Fernanda P. Silveira, MD, Jeffrey Teuteberg, MD, MS, Stephen Weigt, MD, Aimee K. Zaas, MD, MHS, Andreas Zuckerman, MD, and Orla Morrissey, MD, PhD

Adult0301 basic medicinePulmonary and Respiratory Medicinemedicine.medical_specialty2747 TransplantationHeart-Lung Transplantation030106 microbiology610 Medicine & health030230 surgery2705 Cardiology and Cardiovascular Medicine03 medical and health sciencesPostoperative Complications0302 clinical medicinePrevalencemedicineHumansAssisted CirculationChildTransplantationbusiness.industryIncidence2746 SurgerySurgeryMycoses2740 Pulmonary and Respiratory MedicineAdult; Child; Humans; Incidence; Mycoses; Postoperative Complications; Prevalence; Assisted Circulation; Heart-Lung Transplantation; Surgery; Pulmonary and Respiratory Medicine; Cardiology and Cardiovascular Medicine; TransplantationSurgery10178 Clinic for PneumologyCardiology and Cardiovascular MedicinebusinessHumanitiesThe Journal of Heart and Lung Transplantation
researchProduct

Should Vanishing Twin Pregnancies Be Systematically Excluded From Cell-Free Fetal DNA Testing?

2020

Objective To demonstrate the feasibility of cell-free DNA (cfDNA) testing in vanishing twin (VT) pregnancies in routine clinical practice. Methods Our study included 24 874 singleton and 206 VT consecutive pregnancies. Cell-free DNA was analyzed by massively parallel sequencing. Both aneuploidy analysis (chromosomes 13,18, 21, X, and Y) and fetal fraction estimation were performed according to an Illumina algorithm. Contaminant DNA contribution from the demised co-twin was studied in detail. Results VT pregnancies exhibited a higher prevalence of screen-positive cases (5.8% vs 2.5%), sex discrepancies (10.2% vs 0.05%), and false positive rates (FPR) (2.6% vs 0.3%) than singleton pregnancies…

Adult0301 basic medicinemedicine.medical_specialtyAneuploidy030105 genetics & heredity03 medical and health sciences0302 clinical medicinePregnancyPrenatal DiagnosisHumansMedicineGenetics (clinical)Retrospective StudiesVanishing twinFetusPregnancy030219 obstetrics & reproductive medicinebusiness.industryObstetricsSingletonIncidence (epidemiology)Obstetrics and GynecologyGeneral Medicinemedicine.diseaseCell-free fetal DNAPregnancy TwinFemalebusinessTrisomyCell-Free Nucleic AcidsObstetrical & Gynecological Survey
researchProduct

Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy

2020

Introduction. Invasive meningococcal disease (IMD) is one of the most severe vaccine-preventable diseases not yet under control. In Italy, although different anti-meningococcal vaccines are available, their offer among regions is heterogeneous. The aim of this study is to describe the epidemiology of IMD in Italy based on analysis of national surveillance data for 2011–2017 to optimize the vaccination strategy. Methods: IMD surveillance data from the Italian National Health Institute were analysed. Microsoft Excel was used to present trend analysis, stratifying by age and serogroups. Results: In Italy, during the period 2011–2017, the incidence of IMD increased from 0.25 cases/100,000 inhab…

AdultAdolescentDatabases FactualInvasive meningococcal diseasesEpidemiologyMeningococcal VaccinesNO03 medical and health sciencesYoung AdultInvasive meningococcal diseases • epidemiology • surveillance system • anti-meningococcal vaccination strategiesHumansChildSurveillance system0303 health sciencesEvidence-Based Medicine030306 microbiologyInvasive meningococcal diseases Epidemiology Surveillance system Anti-meningococcal vaccination strategiesIncidenceInvasive meningococcal diseaseInfantMiddle AgedMeningococcal InfectionsItalyChild PreschoolPopulation SurveillanceOriginal ArticleAnti-meningococcal vaccination strategiesanti-meningococcal vaccination strategies.Journal of Preventive Medicine and Hygiene
researchProduct

Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.

1988

Four-hundred and seventeen patients undergoing open-heart surgery were followed for more than 9 months after transfusion. All 2270 blood units transfused had alanine aminotransferase levels less than or equal to 30 U/l. Blood units positive for antibodies to hepatitis B core antigen (anti-HBc) were more frequently associated with recipient hepatitis non-A, non-B (HNANB) (13.7%) than anti-HBc-negative units (4.2%) (p less than 0.001). The frequency of HNANB among recipients of at least 1 anti-HBc-positive blood unit (8/79, 10.1%) was fivefold greater than among recipients of exclusively anti-HBc-negative blood units (7/338, 2.1%) (p less than 0.01). In this study the exclusion of donors posi…

AdultAdolescentHepatitis Viral HumanImmunologyBlood DonorsAntigenImmunology and AllergyMedicineHumansAlanine aminotransferaseHepatitis B AntibodiesAgedHepatitisbiologybusiness.industryIncidence (epidemiology)virus diseasesTransfusion ReactionAlanine TransaminaseHematologyMiddle Agedmedicine.diseaseHepatitis B Core AntigensHepatitis Cdigestive system diseasesImmunologybiology.proteinBlood unitsAntibodybusinessDonor screeningHepatitis b coreTransfusion
researchProduct

Syncope in pediatric patients: role of arrhythmias

2009

AdultAdolescentIncidenceInfant NewbornInfantArrhythmias CardiacSyncopeLong QT SyndromeChild PreschoolSyncope pediatric patientsTachycardia SupraventricularHumansAtrioventricular BlockChildSicilyRetrospective Studies
researchProduct

[Herpes Zoster and its prevention in Italy. Scientific consensus statement].

2014

In this paper, an Italian group of experts presents a revision of the available data about epidemiology and prevention of Herpes Zoster (HZ). HZ is an acute viral diseases caused by the reactivation of Varicella Zoster Virus (VZV). HZ is characterized by neurological and dermatological symptoms with a dermatomeric localization. The reactivation of the virus from the latent status in the sensitive ganglia increases with age and failing cell mediated immunity. In Europe, more than 95% of adults presents antibodies against VZV. Incidence of HZ is similar all over the world, related to the age of the population: from 2-3/1000 persons/year in the age group 20 to 50 years to 5/1000 in the 60 year…

AdultAged 80 and overClinical Trials as TopicEvidence-Based MedicineSettore MED/17 - Malattie InfettiveIncidenceSocio-culturaleNeuralgia Postherpeticconsensus statementMiddle AgedSettore MED/42 - Igiene Generale E ApplicataHerpes ZosterAge DistributionItalyRisk Factors80 and overNeuralgiaHerpes Zoster VaccineHumansAdult; Age Distribution; Aged; Aged 80 and over; Clinical Trials as Topic; Evidence-Based Medicine; Herpes Zoster; Herpes Zoster Vaccine; Humans; Incidence; Italy; Middle Aged; Neuralgia Postherpetic; Risk Factors; SicilyPostherpeticSicilyprevention of herpes zosterAgedIgiene e sanita pubblica
researchProduct

Sister-chromatid exchange in cultured lymphocytes of ewes and their newborn lambs

1984

The incidence of sister-chromatid exchange (SCE) in cultured lymphocytes of ewes and their newborn lambs was determined using the BrdU-Giemsa technique. In all ewe-lamb pairs, the SCE rate in the lambs was less than that of the ewes. The mean SCE frequencies per chromosome of the ewes after lambing and of the newborn lambs were 0.1909 and 0.1581, respectively. The statistical analysis shows that a significant difference exists between SCE in the adult female sheep and their lambs. At the same time, a negative correlation was observed between SCE rate and cell proliferation. The results of this study are compared with those of previous reports on age-dependency of SCE.

AdultAgingAdolescentanimal diseasesSister chromatid exchangeBiologyAndrologyPregnancyparasitic diseasesAnimalsHumansStatistical analysisCrossing Over GeneticLymphocytesChildCells CulturedAgedGeneticsSheepAdult femaleIncidence (epidemiology)Domestic sheep reproductionSignificant differenceInfant NewbornInfantChromosomeGeneral MedicineMiddle Agedrespiratory systemAnimals NewbornChild PreschoolFemaleNegative correlationSister Chromatid ExchangeCell DivisionMutation Research Letters
researchProduct

Myopia, the challenge of Ophthalmology and its worldwide “explosive epidemic”

2018

AdultAtropinePediatricsmedicine.medical_specialtyAdolescentExplosive materialContact LensesMEDLINE02 engineering and technology01 natural sciences010309 optics020210 optoelectronics & photonicsRisk Factors0103 physical sciencesMyopia0202 electrical engineering electronic engineering information engineeringmedicineHumansAge of OnsetChildLife StyleLightingLife stylebusiness.industryIncidenceIncidence (epidemiology)Disease progressionGeneral MedicineEyeglassesOphthalmic solutionsDisease ProgressionSunlightMorbidityOphthalmic SolutionsAge of onsetbusinessArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct